CRH
Q4 2026 EPS Estimate
$2.22
Nov 4, 2026
Revenue Estimate
$11.60B
FY2026E EPS$5.93
FY2027E EPS$6.71

Analyst Sentiment

Wall St. Consensus
Buy
21 analysts·High coverage
68
Score
15 Buy (71%)6 Hold (29%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
1571%
Hold
629%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear
$120.00
+22.8%
Consensus
$132.00
+35.1%
Bull
$165.60
+69.5%
12-Month Target Range21 analysts
$120.00$132.00$165.60
Current $97.70Consensus
Current Price
$97.70
Upside to Consensus
$34.30

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)
FY2027
Rev+6.12%
EPS+13.12%
FY2028
Rev+6.22%
EPS+13.40%
FY2029
Rev+7.07%
EPS+15.85%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
MetricFY2026EFY2027EFY2028EFY2029EFY2030E
Revenue Avg$39.69B$42.12B$44.74B$47.90B$50.78B
Low$39.04B$41.70B$41.82B$46.29B$49.07B
High$40.17B$42.44B$48.26B$49.61B$52.59B
EBITDA Avg$9.56B$10.14B$10.77B$11.53B$12.23B
Low$9.40B$10.04B$10.07B$11.15B$11.81B
High$9.67B$10.22B$11.62B$11.94B$12.66B
EBIT Avg$7.21B$7.65B$8.13B$8.70B$9.22B
Low$7.09B$7.57B$7.60B$8.41B$8.91B
High$7.30B$7.71B$8.77B$9.01B$9.55B
Net Income Avg$3.99B$4.51B$5.05B$5.97B$7.01B
Low$3.94B$4.49B$4.70B$5.71B$6.70B
High$4.12B$4.64B$5.73B$6.25B$7.34B
EPS Avg$5.93$6.71$7.61$8.82$10.36
Low$5.83$6.63$6.94$8.43$9.90
High$6.08$6.85$8.46$9.23$10.83
Analysts (Rev / EPS)16 / 1015 / 1215 / 1310 / 107 / 5
Quarterly
MetricQ4 2026Q2 2027Q4 2027
Revenue Avg$7.60B$11.25B$10.09B
Low$7.44B$10.95B$9.83B
High$7.75B$11.44B$10.27B
EBITDA Avg$1.83B$2.71B$2.43B
Low$1.79B$2.64B$2.37B
High$1.87B$2.75B$2.47B
EBIT Avg$1.38B$2.04B$1.83B
Low$1.35B$1.99B$1.79B
High$1.41B$2.08B$1.86B
Net Income Avg$-77M$1.58B$1.19B
Low$-79M$1.53B$1.15B
High$-76M$1.61B$1.21B
EPS Avg$-0.12$2.36$1.77
Low$-0.12$2.28$1.71
High$-0.11$2.41$1.81
Analysts (Rev / EPS)5 / 34 / 14 / 1

Earnings Surprises

Recent Analyst Actions

Jul 31, 2026Stephens
CRH price target lowered to $125 from $135 at Stephens
Target:$125.00
+30.2%from $96.00
Jul 8, 2026Wells Fargo
CRH price target lowered to $132 from $135 at Wells Fargo
Target:$132.00
+24.3%from $106.21
Jun 26, 2026Jefferies
CRH price target raised to $165.60 from $149 at Jefferies
Target:$165.60
+46.5%from $113.05
Apr 15, 2026Morgan Stanley
CRH price target lowered to $139 from $141 at Morgan Stanley
Target:$139.00
+19.6%from $116.19
Feb 20, 2026D.A. Davidson
CRH price target raised to $120 from $116 at DA Davidson
Target:$120.00
-4.1%from $125.17
Jan 29, 2026Wells Fargo
CRH price target lowered to $133 from $138 at Wells Fargo
Target:$133.00
+8.6%from $122.46
Jan 13, 2026Wells Fargo
Wells downgrades CRH to Equal Weight on public-spending concerns
Target:$138.00
+5.0%from $131.38
Jan 8, 2026UBS
CRH price target raised to $147 from $138 at UBS
Target:$147.00
+19.7%from $122.77
Dec 10, 2025Morgan Stanley
CRH price target raised to $140 from $131 at Morgan Stanley
Target:$140.00
+13.2%from $123.67
Dec 8, 2025Deutsche Bank
CRH price target lowered to $139 from $140 at Deutsche Bank
Target:$139.00
+16.3%from $119.49
Oct 20, 2025Barclays
CRH price target raised to $131 from $110 at Barclays
Target:$131.00
+11.5%from $117.46
Oct 14, 2025UBS
CRH initiated with a Buy at UBS
Target:$138.00
+17.4%from $117.54
Oct 9, 2025Morgan Stanley
CRH assumed with an Overweight at Morgan Stanley
Target:$134.00
+13.7%from $117.85
Oct 7, 2025Wells Fargo
CRH initiated with an Overweight at Wells Fargo
Target:$135.00
+16.0%from $116.34
Oct 2, 2025UBS
CRH price target raised to $140 from $125 at Truist
Target:$140.00
+15.6%from $121.10
Oct 1, 2025UBS
CRH price target raised to $152 from $112 at RBC Capital
Target:$152.00
+26.8%from $119.90
Apr 14, 2025RBC Capital
CRH price target lowered to $108 from $127 at RBC Capital
Target:$108.00
+25.9%from $85.78
Feb 28, 2025Berenberg Bank
CRH price target raised to $120 from $115 at Berenberg
Target:$120.00
+17.1%from $102.52
Aug 9, 2024Truist Financial
CRH price target raised to $110 from $100 at Truist
Target:$110.00
+32.9%from $82.79
Jul 9, 2024Morgan Stanley
CRH upgraded to Overweight from Equal Weight at Morgan Stanley
Target:$88.00
+18.6%from $74.23
May 13, 2024Truist Financial
CRH price target raised to $100 from $95 at Truist
Target:$100.00
+19.8%from $83.44
Dec 14, 2023Truist Financial
CRH's NYSE Listing Shift Aims To Boost US Investor Appeal, Analyst Sees Potential Growth
Target:$81.00
+20.0%from $67.50
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.